Elevated levels of HER2-HER2 and HER2-HER3 complexes detected by PLA showed a significant association with decreased recurrent-free survival and a reduction in overall survival of breast cancer patients, proving that PLA and the detection of cellular signaling processes can be successfully implemented in studies on prognostic markers in clinical specimens (131). This evidence concerns the gene ERBB2 and breast carcinoma.